来自德国政府管理的可报销健康应用程序目录的数字健康应用程序-对证据和偏见的系统审查

IF 2.2 Q2 HEALTH CARE SCIENCES & SERVICES
mHealth Pub Date : 2023-10-01 DOI:10.21037/mhealth-23-17
Florian Dittrich, Annabelle Mielitz, Evgenii Pustozerov, Dennis Lawin, Ute von Jan, Urs-Vito Albrecht
{"title":"来自德国政府管理的可报销健康应用程序目录的数字健康应用程序-对证据和偏见的系统审查","authors":"Florian Dittrich, Annabelle Mielitz, Evgenii Pustozerov, Dennis Lawin, Ute von Jan, Urs-Vito Albrecht","doi":"10.21037/mhealth-23-17","DOIUrl":null,"url":null,"abstract":"Background: The Digital Healthcare Act, passed in November 2019, authorizes healthcare providers in Germany to prescribe digital health applications (DiGA) to patients covered by statutory health insurance. If DiGA meet specific efficacy requirements, they may be listed in a special directory maintained by the German Federal Institute for Drugs and Medical Devices. Due to the lack of well-founded app evaluation tools, the objectives were to assess (I) the evidence quality situation for DiGA in the literature and (II) how DiGA manufacturers deal with this issue, as reflected by the apps available in the aforementioned directory.","PeriodicalId":74181,"journal":{"name":"mHealth","volume":"24 1","pages":"0"},"PeriodicalIF":2.2000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Digital health applications from a government-regulated directory of reimbursable health apps in Germany—a systematic review for evidence and bias\",\"authors\":\"Florian Dittrich, Annabelle Mielitz, Evgenii Pustozerov, Dennis Lawin, Ute von Jan, Urs-Vito Albrecht\",\"doi\":\"10.21037/mhealth-23-17\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The Digital Healthcare Act, passed in November 2019, authorizes healthcare providers in Germany to prescribe digital health applications (DiGA) to patients covered by statutory health insurance. If DiGA meet specific efficacy requirements, they may be listed in a special directory maintained by the German Federal Institute for Drugs and Medical Devices. Due to the lack of well-founded app evaluation tools, the objectives were to assess (I) the evidence quality situation for DiGA in the literature and (II) how DiGA manufacturers deal with this issue, as reflected by the apps available in the aforementioned directory.\",\"PeriodicalId\":74181,\"journal\":{\"name\":\"mHealth\",\"volume\":\"24 1\",\"pages\":\"0\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"mHealth\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/mhealth-23-17\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"mHealth","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/mhealth-23-17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:2019年11月通过的《数字医疗法案》授权德国的医疗保健提供者向法定健康保险覆盖的患者开数字健康应用程序(DiGA)。如果DiGA符合特定的功效要求,它们可能会被列在德国联邦药物和医疗器械研究所维护的特殊目录中。由于缺乏可靠的应用程序评估工具,我们的目标是评估(I)文献中DiGA的证据质量状况,(II) DiGA制造商如何处理这一问题,这反映在上述目录中可用的应用程序中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Digital health applications from a government-regulated directory of reimbursable health apps in Germany—a systematic review for evidence and bias
Background: The Digital Healthcare Act, passed in November 2019, authorizes healthcare providers in Germany to prescribe digital health applications (DiGA) to patients covered by statutory health insurance. If DiGA meet specific efficacy requirements, they may be listed in a special directory maintained by the German Federal Institute for Drugs and Medical Devices. Due to the lack of well-founded app evaluation tools, the objectives were to assess (I) the evidence quality situation for DiGA in the literature and (II) how DiGA manufacturers deal with this issue, as reflected by the apps available in the aforementioned directory.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信